160 related articles for article (PubMed ID: 33838295)
21. Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period?
Hernández-Méndez EA; Arreola-Guerra JM; Morales-Buenrostro LE; Ramírez JB; Calleja S; Castelán N; Salcedo I; Vilatobá M; Contreras AG; Gabilondo B; Granados J; Alberú J
Clin Transpl; 2013; ():343-50. PubMed ID: 25095527
[TBL] [Abstract][Full Text] [Related]
22. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
Philogene MC; Zhou S; Lonze BE; Bagnasco S; Alasfar S; Montgomery RA; Kraus E; Jackson AM; Leffell MS; Zachary AA
Hum Immunol; 2018 Apr; 79(4):195-202. PubMed ID: 29428484
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
Pearl MH; Zhang Q; Palma Diaz MF; Grotts J; Rossetti M; Elashoff D; Gjertson DW; Weng P; Reed EF; Tsai Chambers E
Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
[TBL] [Abstract][Full Text] [Related]
24. Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting.
Yu S; Huh HJ; Lee KW; Park JB; Kim SJ; Huh W; Jang HR; Kwon GY; Moon HH; Kang ES
Ann Lab Med; 2020 Sep; 40(5):398-408. PubMed ID: 32311853
[TBL] [Abstract][Full Text] [Related]
25. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
Guzzo I; Morolli F; Camassei FD; Piazza A; Poggi E; Dello Strologo L
Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
[TBL] [Abstract][Full Text] [Related]
26. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II Type 1 Receptor Expression in Renal Transplant Biopsies and Anti-AT1R Antibodies in Serum Indicates the Risk of Transplant Loss.
Sas-Strózik A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Gawlik K; Mazanowska O; Madziarska K; Hałoń A; Krajewska M; Banasik M
Transplant Proc; 2020 Oct; 52(8):2299-2304. PubMed ID: 32448653
[TBL] [Abstract][Full Text] [Related]
28. Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?
Hernández-Méndez EA; Arreola-Guerra JM; Morales-Buenrostro LE; Ramírez JB; Calleja S; Castelán N; Salcedo I; Vilatobá M; Contreras AG; Gabilondo B; Granados J; Alberú J
Rev Invest Clin; 2014; 66(3):218-24. PubMed ID: 25695237
[TBL] [Abstract][Full Text] [Related]
29. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
30. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
Gold A; Fichtner A; Choukair D; Schmitt CP; Süsal C; Dragun D; Tönshoff B
Pediatr Nephrol; 2021 Mar; 36(3):725-729. PubMed ID: 33355703
[TBL] [Abstract][Full Text] [Related]
31. ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
Betjes MGH; Sablik KA; Litjens NHR; Otten HG; de Weerd AE
Hum Immunol; 2021 Feb; 82(2):89-96. PubMed ID: 33358038
[TBL] [Abstract][Full Text] [Related]
32. Pre-transplant AT
Gareau AJ; Wiebe C; Pochinco D; Gibson IW; Ho J; Rush DN; Nickerson PW
Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
34. Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody: A case report and literature review.
Lim JH; Han MH; Kim YJ; Huh S; Kim CD
Medicine (Baltimore); 2021 May; 100(21):e25958. PubMed ID: 34032705
[TBL] [Abstract][Full Text] [Related]
35. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Zmonarski S; Mazanowska O; Krajewska M; Bartoszek D; Zabińska M; Myszka M; Kamińska M; Hałoń A; Dawiskiba T; Szyber P; Sas A; Klinger M
Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
[TBL] [Abstract][Full Text] [Related]
36. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
Pearl MH
Pediatr Transplant; 2024 May; 28(3):e14762. PubMed ID: 38650537
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
[TBL] [Abstract][Full Text] [Related]
38. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review.
Sorohan BM; Ismail G; Leca N; Tacu D; Obrișcă B; Constantinescu I; Baston C; Sinescu I
Transplant Rev (Orlando); 2020 Oct; 34(4):100573. PubMed ID: 33002671
[TBL] [Abstract][Full Text] [Related]
40. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
Pearl MH; Leuchter RK; Reed EF; Zhang Q; Ettenger RB; Tsai EW
Pediatr Nephrol; 2015 Aug; 30(8):1371-4. PubMed ID: 25956702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
